167 related articles for article (PubMed ID: 28856516)
1. Usefulness of esophagogastroduodenoscopy and
Ishibashi-Kanno N; Yamagata K; Uchida F; Hasegawa S; Yanagawa T; Bukawa H
Oral Maxillofac Surg; 2017 Dec; 21(4):391-396. PubMed ID: 28856516
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness of 2-deoxy-2-[18F] fluoro-d-glucose-positron emission tomography/computed tomography for assessing early oral squamous cell carcinoma (cT1-2N0M0).
Yamaga E; Toriihara A; Nakamura S; Asai S; Fujioka T; Yoshimura R; Michi Y; Harada H; Tateishi U
Jpn J Clin Oncol; 2018 Jul; 48(7):633-639. PubMed ID: 29718274
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of esophageal cancer during the pretreatment of hypopharyngeal cancer patients: routinely performed esophagogastroduodenoscopy and FDG-PET/CT findings.
Nakaminato S; Toriihara A; Makino T; Kawano T; Kishimoto S; Shibuya H
Acta Oncol; 2012 May; 51(5):645-52. PubMed ID: 22229748
[TBL] [Abstract][Full Text] [Related]
4. Limitations of FDG-PET and FDG-PET with computed tomography for detecting synchronous cancer in pharyngeal cancer.
Suzuki H; Hasegawa Y; Terada A; Ogawa T; Hyodo I; Suzuki M; Nakashima T; Tamaki T; Nishio M
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1191-5. PubMed ID: 19015450
[TBL] [Abstract][Full Text] [Related]
5. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer.
Hanamoto A; Takenaka Y; Shimosegawa E; Ymamamoto Y; Yoshii T; Nakahara S; Hatazawa J; Inohara H
Ann Nucl Med; 2013 Dec; 27(10):880-5. PubMed ID: 23979967
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic sensitivity of ¹⁸fluorodeoxyglucose positron emission tomography for detecting synchronous multiple primary cancers in head and neck cancer patients.
Kondo N; Tsukuda M; Nishimura G
Eur Arch Otorhinolaryngol; 2012 May; 269(5):1503-7. PubMed ID: 21984059
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer.
Miyazaki T; Sohda M; Higuchi T; Tanaka N; Suzuki S; Sakai M; Yokobori T; Nakajima M; Fukuchi M; Tsushima Y; Kato H; Kuwano H
Anticancer Res; 2014 Jan; 34(1):283-7. PubMed ID: 24403475
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of [18F]fluorodeoxyglucose positron emission tomography and computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with palpably negative neck.
Ng SH; Yen TC; Chang JT; Chan SC; Ko SF; Wang HM; Lee LY; Kang CJ; Wong AM; Liao CT
J Clin Oncol; 2006 Sep; 24(27):4371-6. PubMed ID: 16983105
[TBL] [Abstract][Full Text] [Related]
9. Results of esophagogastroduodenoscopy in patients with oral squamous cell carcinoma--value of endoscopic screening: 10-year experience.
Kesting MR; Schurr C; Robitzky L; Steinstraesser L; Nieberler M; Baurecht H; Wolff KD; Loeffelbein DJ; Mücke T
J Oral Maxillofac Surg; 2009 Aug; 67(8):1649-55. PubMed ID: 19615577
[TBL] [Abstract][Full Text] [Related]
10. Impact of [18F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients.
Fleming AJ; Smith SP; Paul CM; Hall NC; Daly BT; Agrawal A; Schuller DE
Laryngoscope; 2007 Jul; 117(7):1173-9. PubMed ID: 17603315
[TBL] [Abstract][Full Text] [Related]
11. (18)F-FDG-PET/CT versus panendoscopy for the detection of synchronous second primary tumors in patients with head and neck squamous cell carcinoma.
Haerle SK; Strobel K; Hany TF; Sidler D; Stoeckli SJ
Head Neck; 2010 Mar; 32(3):319-25. PubMed ID: 19626642
[TBL] [Abstract][Full Text] [Related]
12. Detection of extraoral primary cancers by positron emission tomography/computed tomography in patients with oral squamous cell carcinoma.
Ohsako T; Shimamoto H; Tomioka H; Hirai H; Kuroshima T; Mochizuki Y; Kugimoto T; Tsushima F; Nakamura S; Kurabayashi T; Harada H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2020 Mar; 129(3):272-276. PubMed ID: 31982370
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of ¹⁸F-α-methyl tyrosine PET/CT for the detection of bone marrow invasion in patients with oral squamous cell carcinoma: comparison with ¹⁸F-FDG PET/CT and MRI.
Kim M; Higuchi T; Arisaka Y; Achmad A; Tokue A; Tominaga H; Miyashita G; Miyazaki H; Negishi A; Yokoo S; Tsushima Y
Ann Nucl Med; 2013 Jun; 27(5):423-30. PubMed ID: 23436243
[TBL] [Abstract][Full Text] [Related]
14. Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and
Rohde M; Nielsen AL; Johansen J; Sørensen JA; Nguyen N; Diaz A; Nielsen MK; Asmussen JT; Christiansen JM; Gerke O; Thomassen A; Alavi A; Høilund-Carlsen PF; Godballe C
J Nucl Med; 2017 Dec; 58(12):1919-1924. PubMed ID: 28572489
[TBL] [Abstract][Full Text] [Related]
15. Dual-phase F-18 FDG PET-CT in staging and lymphoscintigraphy for detection of sentinel lymph nodes in oral cavity cancers.
Sürücü E; Polack BD; Demir Y; Durmuşoğlu M; Ekmekçi S; Sarıoğlu S; Çelik AO; Ada E; İkiz AÖ
Clin Imaging; 2015; 39(5):781-6. PubMed ID: 25721710
[TBL] [Abstract][Full Text] [Related]
16. Synchronous malignancies in patients with squamous cell carcinomas of the oral cavity.
Liu FY; Liao CT; Yen TC
Eur J Nucl Med Mol Imaging; 2011 Jun; 38(6):1020-8. PubMed ID: 21359612
[TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG-PET/CT for systemic staging of newly diagnosed triple-negative breast cancer.
Ulaner GA; Castillo R; Goldman DA; Wills J; Riedl CC; Pinker-Domenig K; Jochelson MS; Gönen M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1937-44. PubMed ID: 27129866
[TBL] [Abstract][Full Text] [Related]
18. Clinical values of (18) F-FDG PET/CT in oral cavity cancer with dental artifacts on CT or MRI.
Hong HR; Jin S; Koo HJ; Roh JL; Kim JS; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2014 Nov; 110(6):696-701. PubMed ID: 24995957
[TBL] [Abstract][Full Text] [Related]
19. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
